KalVista Pharmaceuticals (KALV) Treasury Shares (2020 - 2025)
KalVista Pharmaceuticals recorded quarterly Treasury Shares of $177500.0 in Q2 2025, down 71.66% quarter-over-quarter from $626272.0 in Q2 2024, and down 71.66% year-over-year from $626272.0 in Q2 2024.
KalVista Pharmaceuticals' Treasury Shares history runs 4 years deep, the most recent figure standing at $177500.0 for Q2 2025.
- In Q2 2025, Treasury Shares fell 71.66% year-over-year to $177500.0; the TTM figure through Apr 2025 stood at $177500.0 (down 71.66% YoY), while the FY2025 annual figure was $177500.0, down 71.66% from the prior year.
- Treasury Shares came in at $177500.0 for Q2 2025 at KalVista Pharmaceuticals, down from $626272.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $742242.0 in Q2 2023 to a low of $177500.0 in Q2 2025.
- A 3-year average of $515338.0 and a median of $626272.0 in 2024 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares dropped 15.62% in 2024 and tumbled 71.66% in 2025, its largest moves.
- KalVista Pharmaceuticals' Treasury Shares stood at $742242.0 in 2023, then dropped by 15.62% to $626272.0 in 2024, then slumped by 71.66% to $177500.0 in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered $177500.0, $626272.0, and $742242.0 for Q2 2025, Q2 2024, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 177,500.00 |
| Apr 30, 2025 | 177,500.00 |
| Apr 30, 2024 | 626,272.00 |
| Apr 30, 2024 | 626,272.00 |
| Apr 30, 2023 | 742,242.00 |
| Apr 30, 2023 | 742,242.00 |
| Apr 30, 2020 | 45,000.00 |
| Apr 30, 2020 | 45,000.00 |